Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese

Biochemical and Biophysical Research Communications

Volumn 316, Issue 3, 2004, Pages 744-748

  Yamamoto, Miyuki ^a   Abe, Michiko ^a   Jin, Jing Ji ^a   Wu, Zhihong ^a   Tabara, Yasuharu ^a   Mogi, Masaki ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Nakura, Jun ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; G protein; Hypertension; Multiple risk factor clustering syndrome

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SUBUNIT;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE; GNB3 GENE; HOMOZYGOTE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; JAPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PULSE PRESSURE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ARTERIOSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; DNA; FEMALE; GENOTYPE; HETEROTRIMERIC GTP-BINDING PROTEINS; HOMOZYGOTE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 1642325814     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.113     Document Type: Article

References (44)

1. Conklin B.R., Bourne H.R. Structural elements of G alpha subunits that interact with G beta gamma, receptors, and effectors. Cell. 73:1993;631-641.
2. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257.
3. Rens-Domiano S., Hamm H.E. Structural and functional relationships of heterotrimeric G-proteins. FASEB J. 9:1995;1059-1066.
4. Clapham D.E., Neer E.J. G protein beta gamma subunits. Annu. Rev. Pharmacol. Toxicol. 37:1997;167-203.
5. Siffert W., Rosskopf D., Siffert G., Busch S., Moritz A., Erbel R., Sharma A.M., Ritz E., Wichmann H.E., Jakobs K.H., Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat. Genet. 18:1998;45-48.
6. Schunkert H., Hense H.W., Doring A., Riegger G.A., Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension. 32:1998;510-513.
7. Benjafield A.V., Jeyasingam C.L., Nyholt D.R., Griffiths L.R., Morris B.J. G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension. 32:1998;1094-1097.
8. Beige J., Hohenbleicher H., Distler A., Sharma A.M. G-protein beta3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension. 33:1999;1049-1051.
9. Siffert W., Forster P., Jockel K.H., Mvere D.A., Brinkmann B., Naber C., Crookes R., Du P.H., Epplen J.T., Fridey J., Freedman B.I., Muller N., Stolke D., Sharma A.M., al Moutaery K., Grosse-Wilde H., Buerbaum B., Ehrlich T., Ahmad H.R., Horsthemke B., Du Toit E.D., Tiilikainen A., Ge J., Wang Y., Rosskopf D. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J. Am. Soc. Nephrol. 10:1999;1921-1930.
10. Hegele R.A., Anderson C., Young T.K., Connelly P.W. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res. 9:1999;972-977.
11. Gutersohn A., Naber C., Muller N., Erbel R., Siffert W. G protein beta3 subunit 825 TT genotype and post-pregnancy weight retention. Lancet. 355:2000;1240-1241.
12. Poch E., Giner V., Gonzalez-Nunez D., Coll E., Oriola J., de la Sierra A. Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin. Exp. Hypertens. 24:2002;345-353.
13. Rosskopf D., Frey U., Eckhardt S., Schmidt S., Ritz E., Hofmann S., Jaksch M., Muller N., Husing J., Siffert W., Jocke K.H. Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes. Eur. J. Med. Res. 5:2000;484-490.
14. Naber C.K., Husing J., Wolfhard U., Erbel R., Siffert W. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension. 36:2000;986-989.
15. Morrison A.C., Doris P.A., Folsom A.R., Nieto F.J., Boerwinkle E. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke: atherosclerosis risk in communities study. Stroke. 32:2001;4822-4829.
16. Hata Y., Mabuchi H., Saito Y., Itakura H., Egusa G., Ito H., Teramoto T., Tsushima M., Tada N., Oikawa S., Yamada N., Yamashita S., Sakuma N., Sasaki J. Report of the Japan Atherosclerosis Society (JAS) guideline for diagnosis and treatment of hyperlipidemia in Japanese adults: Working committee on JAS guideline for diagnosis and treatment of hyperlipidemias. J. Atheroscler. Thromb. 9:2002;1-27.
17. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15:1998;539-553.
18. Holloway J.W., Beghe B., Turner S., Hinks L.J., Day I.N., Howell W.M. Comparison of three methods for single nucleotide polymorphism typing for DNA bank studies: sequence-specific oligonucleotide probe hybridisation, TaqMan liquid phase hybridisation, and microplate array diagonal gel electrophoresis (MADGE). Hum. Mutat. 14:1999;340-347.
19. Ishikawa K., Baba S., Katsuya T., Iwai N., Asai T., Fukuda M., Takiuchi S., Fu Y., Mannami T., Ogata J., Higaki J., Ogihara T. T. + 31C polymorphism of angiotensinogen gene and essential hypertension Hypertension. 37:2000;281-285.
20. ′ nuclease (Taqman(R)) assay Hum. Mutat. 19:2002;395-401.
21. de Kok J.B., Wiegerinck E.T., Giesendorf B.A., Swinkels D.W. Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum. Mutat. 19:2002;554-559.
22. Dart A.M., Kingwell B.A. Pulse pressure - a review of mechanisms and clinical relevance. J. Am. Coll. Cardiol. 37:2001;975-984.
23. Kato N., Sugiyama T., Morita H., Kurihara H., Yamori Y., Yazaki Y. G protein beta3 subunit variant and essential hypertension in Japanese. Hypertension. 32:1998;935-938.
24. Ishikawa K., Imai Y., Katsuya T., Ohkubo T., Tsuji I., Nagai K., Takami S., Nakata Y., Satoh H., Hisamichi S., Higaki J., Ogihara T. Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am. J. Hypertens. 13:2000;140-145.
25. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
26. Uemura K., Nakura J., Kohara K., Miki T. Association of ACE I/D polymorphism with cardiovascular risk factors. Hum. Genet. 107:2000;239-242.
27. Moskowitz D.W. From pharmacogenomics to improved patient outcomes: angiotensin I-converting enzyme as an example. Diabetes Technol. Ther. 4:2002;519-532.
28. Moskowitz D.W. Is angiotensin I-converting enzyme a "master" disease gene? Diabetes Technol. Ther. 4:2002;683-711.
29. Iiri T., Farfel Z., Bourne H.R. G-protein diseases furnish a model for the turn-on switch. Nature. 394:1998;35-38.
30. Su H.L., Malbon C.C., Wang H.Y. Increased expression of Gi alpha 2 in mouse embryo stem cells promotes terminal differentiation to adipocytes. Am. J. Physiol. 265:1993;1729-1735.
31. Wang H.Y., Malbon C.C. The Gs alpha/Gi alpha 2 axis controls adipogenesis independently of adenylylcyclase. Int. J. Obes. Relat. Metab. Disord. 20:1996;S26-S31.
32. Gasic S., Tian B., Green A. Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J. Biol. Chem. 274:1999;6770-6775.
33. Hauner H., Rohrig K., Siffert W. Effects of the G-protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm. Metab. Res. 34:2002;475-480.
34. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259:1993;87-91.
35. Anand-Srivastava M.B. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition. Biochem. J. 288:1992;79-85.
36. Thibault C., Anand-Srivastava M.B. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett. 313:1992;160-164.
37. Anand-Srivastava M.B., de Champlain J., Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am. J. Hypertens. 6:1993;72-75.
38. Di Fusco F., Anand-Srivastava M.B. Enhanced expression of Gi proteins in non-hypertrophic hearts from rats with hypertension-induced by L-NAME treatment. J. Hypertens. 18:2000;1081-1090.
39. Li Y., Anand-Srivastava M.B. Inactivation of enhanced expression of G(i) proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ. Res. 91:2002;247-254.
40. Fogari R., Zoppi A., Tettamanti F., Poletti L., Lazzari P., Pasotti C., Corradi L. Beta-blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment. J. Cardiovasc. Pharmacol. 16:1990;S76-S80.
41. Fogari R., Zoppi A., Corradi L., Preti P., Mugellini A., Lusardi P. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J. Cardiovasc. Pharmacol. 33:1999;534-539.
42. Moxham C.M., Malbon C.C. Insulin action impaired by deficiency of the G-protein subunit Gi alpha2. Nature. 379:1996;840-844.
43. Chen J.F., Guo J.H., Moxham C.M., Wang H.Y., Malbon C.C. Conditional, tissue-specific expression of Q205L G alpha i2 in vivo mimics insulin action. J. Mol. Med. 75:1997;283-289.
44. Tao J., Malbon C.C., Wang H.Y. G alpha (i2) enhances insulin signaling via suppression of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276:2001;39705-39712.